Schonfeld Strategic Advisors’s Seres Therapeutics MCRB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-29,097	Closed	-$433K	–	2476
2025 Q4	$433K	Buy	29,097 +155	+0.5%	+$2.7K	﹤0.01%	1446
2025 Q3	$557K	Buy	+28,942	New	+$462K	﹤0.01%	1643
2025 Q2	–	Sell	-2,565	Closed	-$35.9K	–	2334
2025 Q1	$35.9K	Sell	2,565 -2,470	-49%	-$38.7K	﹤0.01%	2083
2024 Q4	$83.7K	Sell	5,035 -16,660	-77%	-$271K	﹤0.01%	1849
2024 Q3	$411K	Buy	21,695 +18,690	+622%	+$379K	﹤0.01%	1524
2024 Q2	$43.5K	Buy	+3,005	New	+$50.1K	﹤0.01%	1950
2023 Q3	–	Sell	-11,113	Closed	-$1.06M	–	2081
2023 Q2	$1.06M	Buy	+11,113	New	+$1.21M	0.01%	944
2021 Q3	–	Sell	-5,330	Closed	-$2.54M	–	2339
2021 Q2	$2.54M	Buy	+5,330	New	+$2.25M	0.03%	644
2021 Q1	–	Sell	-723	Closed	-$355K	–	2006
2020 Q4	$355K	Buy	723 +123	+21%	+$72K	﹤0.01%	1150
2020 Q3	$339K	Buy	+600	New	+$200K	0.01%	1053